Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07122492) titled 'A Targeted Electronic Health Approach to Reduce Fear of Recurrence in Breast Cancer Survivors (FoRtitude)' on Aug. 7.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Eastern Cooperative Oncology Group
Condition:
Breast Cancer Survivor
Fear of Cancer Recurrence
Intervention:
Behavioral: FoRtitude 2.0
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 1, 2025
Target Sample Size: 800
Countries of Recruitment:
United States
To know more, visit https:...